Lumida
/EHTH
⌘K
eHealth Inc

eHealth Inc

EHTH
$1.49USD+0.00%+0.00 today

MARKET CAP

47.3M

P/E (TTM)

FWD P/E

1.5x

DAY RANGE

$1 – $2

52W RANGE

$1
$6

AI Summary

Stalk
Sell NowMedium

EHTH is in a Stage 4 decline with confirmed lower highs and lower lows, trading below declining EMAs that act as resistance. Medium-term asymmetry remains bearish, and short-term timing is bearish as price tightly tracks under sloping EMAs. Execution should occur now via a rejection at the 9/20/50 EMA cluster. A sustained close and acceptance above the EMA zone and a subsequent higher swing high would invalidate this bearish medium-term bias.

  • FY25 revenue guidance of $525–565 M indicates strong growth trajectory.
  • Targeted $30 M fixed cost cuts for 2026 improve operating leverage.
  • Q1’26 revenue declined 22% YoY to $88 M with a net loss of $4.7 M.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

eHealth Inc. (NASDAQ: EHTH) is an emerging player within the digital health insurance marketplace, specializing in Medicare enrollment solutions. The company is primarily focused on connecting seniors to Medicare options, thereby facilitating easier navigation of complex healthcare choices. Positioned to cater to an accelerating demand due to an aging population, eHealth's innovative approach reflects an attempt to stand out in a competitive and rapidly evolving landscape. They are concentrating on new advisory models and ancillary products to diversify their offerings, aiming for sustainable growth amidst recent regulatory shifts in the Medicare Advantage sector.

Bull says

  • FY25 revenue guidance of $525–565 M indicates strong growth trajectory.
  • Targeted $30 M fixed cost cuts for 2026 improve operating leverage.
  • Lifetime advisory model rollout aims to boost retention and customer LTV.
  • Customer acquisition cost declined 10% YoY, showing marketing efficiency.
  • Cash balance of $105.2 M provides liquidity for growth investments.
  • High earnings yield, strong book‐to‐price ratio, and positive analyst revisions support valuation.

Bear says

  • Q1’26 revenue declined 22% YoY to $88 M with a net loss of $4.7 M.
  • Medicare segment revenue dropped to $81.3 M amid lower member enrollments.
  • Dual-eligible enrollment rule changes are expected to further reduce volumes.
  • Weak stock momentum and elevated volatility signal negative investor sentiment.
  • Profit margins are pressured by rising operating costs, straining cash flow.
  • Weak profitability factor and negative dividend yield point to low returns.

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-12-2026neutral

Transcript signals

Bull points

  • We're pleased with our first quarter results, which came in ahead of expectations, driven by stronger than anticipated Medicare enrollment volume and favorable unit economics.
  • First quarter revenue was $88 million, ahead of our expectations. Gap net loss was 4.7 million, and adjusted EBITDA was 9 million, exceeding our internal plan.
  • This includes providing ancillary and post-enrollment services. During the quarter, we implemented headcount reductions and vendor consolidation initiatives. These actions are expected to reduce our fixed operating cost base by approximately $30 million in 2026 compared to 2025, representing roughly a 20% reduction.

Bear points

  • While this is just one variable in the system, We believe it is an important signal that CMS leadership is responsive to industry feedback and focused on long-term program sustainability. That said, we are early in the planning cycle for the upcoming annual enrollment period.
  • First quarter 2026 total revenue was $88 million, representing a 22% decline.
  • Medicare segment revenue also declined 22% to $81.3 million, driven primarily by lower enrollment volume as we reduced variable marketing spend to focus on our best performing channels.
Read full transcript analysis ›